Ceibo Appoints Global Mining Leader Ian Pearce to its Board of Directors
SANTIAGO, Chile–(BUSINESS WIRE)–Ceibo, the technology company pioneering next-generation copper extraction, today announced the appointment of Ian Pearce... Read more.
Gauzy Ltd. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – GAUZ
LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Gauzy Ltd. (“Gauzy” or “the Company”) (NASDAQ:... Read more.
ProCap Financial Purchases More Bitcoin and Joins the 5,000 Bitcoin Club
NEW YORK–(BUSINESS WIRE)–ProCap Financial (Nasdaq: BRR), a modern financial services firm leveraging Bitcoin, today announced the Company increased its... Read more.
StandardAero Announces Board Authorization of $450 Million Stock Repurchase Program
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–StandardAero, Inc. (NYSE: SARO) (“StandardAero” or the “Company”), a leading independent pure-play provider... Read more.
APi Group Announces Acquisition of CertaSite and Provides Full-Year 2025 Update
-Accretive to APi’s “10/16/60+” long-term financial targets- – Accelerates inspection-first strategy and shifts mix towards 60% of revenues from inspection,... Read more.
Give Back Health Innovation Foundation Partners with Inteligex to Bring Innovative Therapy to Life for Canadians
First-of-its-kind funding model to support health innovation and accelerate outcomes for Canadians suffering from spinal cord injuries TORONTO–(BUSINESS WIRE)–Give... Read more.
Chewy Announces Third Quarter 2025 Financial Results
PLANTATION, Fla.–(BUSINESS WIRE)–Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released... Read more.
NeoGenomics to Present New ctDNA Research at SABCS 2025
Data include findings generated using the RaDaR 1.0 assay to assess molecular residual disease and recurrence risk in early breast cancer FORT MYERS, Fla.–(BUSINESS... Read more.
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
Believes STAAR’s Sale Process Was Structured to Seal the Alcon Deal, Not to Maximize Value for Shareholders The Company Is Not Ripe for Sale at This Time Continues... Read more.
Ensoma Announces Clearance of U.K. Clinical Trial Authorization Application for EN-374, First In Vivo HSC-Directed Gene Insertion Therapy
MHRA authorization to initiate Phase 1/2 clinical trial at U.K. sites follows first U.S. patient dosing with EN-374 for treatment of X-linked chronic granulomatous... Read more.